Clinical Trials Browser

OTHER × nirogacestat × Clear all

NCT05556798 2026-02-24

A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

Phase 1 Active not recruiting

Multiple Myeloma

NCT05879146 2026-02-19

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

Phase 2 Recruiting

Neoplasms

NCT05949099 2025-09-08

Study of Cryoablation and Nirogacestat for Desmoid Tumor

Phase 2 Recruiting

Desmoid Tumors

NCT05573802 2023-10-24

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

Phase 1/2 Recruiting

Blood Protein Disorders, Corneal Diseases, Hematologic Diseases, Multiple Myeloma, Neoplasms, Paraproteinemias, Neoplasms, Plasma Cell

NCT02955446 2019-02-01

Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies

No longer available

Neoplasms, Desmoid Tumors

NCT02338531 2016-04-29

RHEA

Phase 2 Withdrawn

Breast Neoplasms